Glooko, Inc

Glooko is a digital health platform specializing in diabetes management and glycemic control. The company operates two primary product lines: the outpatient Glooko Diabetes Management Platform and the inpatient EndoTool Glucose Management System (acquired via Monarch Medical Technologies). The outpatient platform integrates data from over 200 diabetes and health monitoring devices, providing seamless connectivity with continuous glucose monitors (CGMs), blood glucose meters, and wearables. It enables remote patient monitoring, population health management, and secure remote collaboration between patients and care teams through the Glooko Mobile App and clinic dashboard. EndoTool is a patient-specific insulin dosing system designed for hospital inpatient glycemic management, with clinical data showing virtual elimination of severe hypoglycemia. Glooko serves 8,000+ clinics across 30+ countries, providing actionable insights to streamline clinical workflows and improve diabetes outcomes. Clinical evidence demonstrates 18% reduction in average blood glucose within three months and sustained HbA1c improvements. The company maintains robust security and privacy compliance including HITRUST, HIPAA, SOC 2 Type II, ISO 27001, and GDPR certifications, ensuring enterprise-grade data protection for patient health information. Glooko's platform is built on device connectivity standards and interoperability principles to eliminate fragmented data across healthcare systems. The company targets hospitals, health systems, clinics, and individual patients requiring comprehensive diabetes data management and remote monitoring capabilities.